{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-071364","form_type":"8-K","ticker":"CAPR","cik":"0001133869","company_name":"CAPRICOR THERAPEUTICS, INC.","filed_at":"2026-06-08T20:05:07+00:00","discovered_at":"2026-06-08T20:06:00.712213+00:00","generated_at":"2026-06-08T20:12:07.355674+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Capricor shareholders fail to approve officer exculpation amendment at annual meeting","bullets":["All eight director nominees elected; Linda Marbán, Ph.D. re-elected with 25.5M votes for.","Ratification of Rose, Snyder & Jacobs LLP as auditor passed with 43.1M votes for.","Advisory vote on executive compensation approved (24.3M for, 6.2M against).","Non-binding vote favored '1 Year' frequency for future say-on-pay votes (29.8M of votes cast).","Amendment to certificate for officer exculpation failed: 23.5M for, 6.4M against, 13M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-071364","json":"https://secwatch.observer/filing/0001104659-26-071364.json","markdown":"https://secwatch.observer/filing/0001104659-26-071364.md","text":"https://secwatch.observer/filing/0001104659-26-071364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133869/000110465926071364/0001104659-26-071364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133869/000110465926071364/capr-20260604x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T20:12:07.355674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}